Feb 5, 2026 08:05AM
Feb 5, 2026 08:05AM
Nov 13, 2025 07:45AM
Nov 10, 2025 07:31AM
Nov 10, 2025 07:30AM
Nov 10, 2025 07:30AM
Nov 10, 2025 07:30AM IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
Oct 30, 2025 08:00AM
Oct 30, 2025 08:00AM
Oct 23, 2025 10:01AM
Oct 23, 2025 10:01AM
Oct 14, 2025 08:20AM
Oct 14, 2025 08:20AM
Jun 17, 2025 08:05AM Imunon (IMNN) Announces PlaCCine DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development
Jun 17, 2025 08:05AM
Jun 17, 2025 08:05AM
May 23, 2025 08:05AM
May 15, 2025 08:06AM
May 15, 2025 08:05AM
May 12, 2025 08:00AM
Mar 24, 2025 08:05AM Imunon (IMNN) Finalizes Phase 3 Study Design with FDA for IMNN-001
Mar 24, 2025 08:00AM
Feb 28, 2025 08:09AM
Feb 27, 2025 08:05AM
Nov 26, 2024 07:06AM
Nov 7, 2024 08:05AM
Oct 31, 2024 08:30AM
Oct 30, 2024 09:05AM IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting
Sep 9, 2024 04:06PM
Sep 9, 2024 08:30AM
Aug 14, 2024 08:00AM
May 13, 2024 08:00AM
Apr 18, 2024 08:31AM
Apr 18, 2024 08:30AM
Apr 11, 2024 08:00AM Imunon (IMNN) Regains Nasdaq Compliance
Apr 11, 2024 08:00AM
Mar 28, 2024 08:00AM
Mar 13, 2024 08:00AM
Mar 13, 2024 08:00AM
Feb 29, 2024 08:31AM
Feb 29, 2024 08:30AM
Feb 22, 2024 08:00AM IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine
Nov 14, 2023 08:00AM
Oct 23, 2023 08:30AM
Aug 10, 2023 08:00AM
Jun 27, 2023 12:00PM
May 30, 2023 08:00AM
May 11, 2023 08:00AM
Mar 30, 2023 08:00AM IMUNON Reports 2022 Financial Results and Provides Business Update
Mar 1, 2023 08:45AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All